HOME >> BIOLOGY >> NEWS
Anthrax drugs used to treat adults can treat children, too

COLUMBUS, Ohio - The two drugs most commonly used to treat anthrax in adults could cause unwanted side effects if used in children, according to an analysis of pediatric anthrax treatment options.

But the risks of using either medication pale in comparison to the risks of anthrax disease, said Milap Nahata, a professor and chair of pharmacy practice and administration at Ohio State.

"Anthrax can be fatal, and children may have the greatest risk for developing the disease in the event of a major bioterrorism attack," he said. "So the use of these antibiotics can be recommended despite the lack of adequate efficacy and safety studies in children." The researchers analyzed nearly 20 studies that examined the safety and efficacy of two medications - ciprofloxacin and doxycycline -- when used in children. The drugs are also often used to treat adults with the disease.

Past research links ciprofloxacin (or cipro) to bone deformations and doxycycline to bone growth inhibition and tooth discoloration in children.

Nahata conducted the study with Sandra Benavides, a postdoctoral fellow in pharmacy at Ohio State. Their analysis appears in a recent issue of The Annals of Pharmacology.

Anthrax infectio
'"/>

Contact: Milap Nahata
Nahata.1@osu.edu
614-292-2472
Ohio State University
22-Apr-2002


Page: 1 2 3 4

Related biology news :

1. Anthrax enzyme images reveal secrets of antibiotic resistance, suggest new drug design
2. Anthrax spores can germinate, grow and reproduce in soil
3. Anthrax research might provide more time for treatment
4. Anthrax: A soil bug gone bad
5. Anthrax threat needs aggressive government action plan, say researchers
6. CDC MMWR: Fetal Alcohol Syndrome and Cutaneous Anthrax in a Lab Worker
7. Anthrax spores use failsafe protection system, say U-M scientists
8. Anthrax genome may contain new clues to fight infection, says Science Functional Genomics article
9. Anthrax dectectors are coming
10. Anthrax - Trail of terror
11. Anthrax - How to protect ourselves

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/3/2020)... ... August 03, 2020 , ... Accumen Inc. is helping ... equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing kits nationally. , ... for more than 10 years. Early in the COVID-19 crisis, we identified supply ...
(Date:7/18/2020)... ... ... Commercial launch readiness is a critical stage in a product life cycle. ... the global economic downturn will only increase price pressures overall for the industry. The ... value from every product launch is critical. However, history shows that only a third ...
(Date:7/2/2020)... FREDERICK, Md. (PRWEB) , ... ... ... company, Molecular Biology Systems, B.V. (MBS) has announced a publication detailing the ... a one-step reverse transcription polymerase chain reaction (RT-PCR) in 16 minutes. The ...
Breaking Biology News(10 mins):
(Date:7/22/2020)... ... ... Join experts from Reed Tech , Gary Saner, Sr. Manager, Information Solutions ... live webinar on Thursday, August 13, 2020 at 11am EDT (4pm BST/UK). , ... for medical devices, the NMPA has departments dealing with medical device registration (pre-market approvals) ...
(Date:7/18/2020)... ... , ... “We are thrilled to deliver this new technology to the industry” ... kind on the market and we were pleased that the IFT jury recognized that.” ... ingredients, creating a natural way to extend the shelf life and improve the safety ...
(Date:7/18/2020)... ... , ... dicentra , a leading Contract Research Organization ... pleased to announce that Charles Galea has joined its clinical trials division as ... accomplished and results-driven sales executive with over 10 years of expertise in business ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
Breaking Biology Technology:
Cached News: